Toshio Sada

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

Masaomi Nangaku, Toshio Miyata, Toshio Sada et al. · Journal of the American Society of Nephrology · 2003 · 175 citations · Full text

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

Makoto Mizuno, Toshio Sada, Masahiro Ikeda et al. · European Journal of Pharmacology · 1995 · 155 citations

Molecular Pharmacology, Hypertension, Medicine +7

Nonpeptide Angiotensin II Receptor Antagonists:  Synthesis, Biological Activities, and Structure−Activity Relationships of Imidazole-5-carboxylic Acids Bearing Alkyl, Alkenyl, and Hydroxyalkyl Substituents at the 4-Position and Their Related Compounds

Hiroaki Yanagisawa, Yoshiya Amemiya, Takuro Kanazaki et al. · Journal of Medicinal Chemistry · 1996 · 142 citations · Full text

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

Kiyoshi Arai, Tsuyoshi Homma, Yuka Morikawa et al. · European Journal of Pharmacology · 2015 · 132 citations

Physiology, Pharmacology, Pharmacological Agent +6

Cytosolic free calcium of aorta in hypertensive rats. Chronic inhibition of angiotensin converting enzyme.

Toshio Sada, H Koike, Masahiro Ikeda et al. · Hypertension · 1990 · 78 citations · Full text

Cardiac Muscle, Hypertension, Cytosolic Free Calcium +18